Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DOXOrubicin HCl safely and effectively. See full prescribing information for Doxorubicin HCl. DOXOrubicin HCl Injection, USP, for intravenous use Initial U.S. Approval: 1974
Medication labelWhy this: Advisory · dailymed-prescription
DOXOrubicin HCl Injection, USP is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer [see Clinical Studies (14.1)]. Doxorubicin is indicated for the treatment of acute lymphoblastic leukemia acute myeloblastic leukemia Hodgkin lymphoma non-Hodgkin lymphoma (NHL) metastatic breast cancer metastatic Wilms’ tumor metastatic neuroblastoma metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma
- generic_name
- doxorubicin hydrochloride
- product_names
- Doxorubicin Hydrochloride
- ndc
- 0143-9084, 0143-9084-01, 0143-9085, 0143-9085-01, 0143-9086, 0143-9086-01, 0143-9087, 0143-9087-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en